Quantitative Longitudinal Imaging of Vascular Inflammation and Treatment by Ezetimibe in apoE Mice by FMT Using New Optical Imaging Biomarkers of Cathepsin Activity and 𝜶_𝑣𝜷_𝟑 Integrin

Table 2

Serum cholesterol levels and plasma ezetimibe concentration (Mean ± SD) of ezetimibe treated and control apoE^−/− mice.

Group	HDL-C; (mg/dL)	(LDL + VLDL)-C; (mg/dL)	Ezetimibe; (μM)
Control	11.5 ± 0.9	411 ± 59	Undetectable
Treated	32.5 ± 2.9	106 ± 27	0.55 ± 0.11